Navigation Links
Medbox, Inc. Posts Record Revenues in 3rd Quarter 2013 Financials
Date:11/20/2013

HOLLYWOOD, Calif., Nov. 20, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced today that they have posted their 3rd Quarter 2013 financials.

Highlights of 3rd Quarter Financials include:

  • Revenues surged to over $5.046 million through three quarters, making 2013 the company's best revenue generating year in the company's history.
  • Revenues reported of $2.079 million for 3rd quarter of 2013, making it the highest grossing quarter in the company's history.
  • Assets more than doubled from year-end 2012, from $3.5 million to over $7.2 million.
  • Gross profit margin for the quarter was a healthy $833 thousand and EBITDA margin for the quarter was approximately 21%.
  • Income from operations through 3 quarters, before taxes, was a healthy $647 thousand.

"We have had another record breaking quarter, which provides further validation that our business plan is solid and our operating strategy is sound," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "As we move forward, we will continue to seek out opportunities that provide growth for our company and added value for our shareholders."

The company also announced that they have brought accounting functions in-house to help expedite preparation of statements and reports.

"As we continue to mature and transition to being a fully reporting company, we need to be able to provide timely reports, status updates, and filings," Bedrick commented. "We have assembled an in-house team of accounting professionals. This team can devote more time to work seamlessly with our outside auditing firm so that we meet our deadlines and obligations, and provide the most accurate and timely information to the SEC and the general public."

The Q3 2013 financials are listed on the company's website at: http://www.thedispensingsolution.com/wp-content/uploads/2013/11/Medbox-FS-Notes-Q3-2013.pdf

The filing may also be accessed through the company's landing page on OTC Markets at: http://www.otcmarkets.com/financialReportViewer?symbol=MDBX&id=113733

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Florida, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.


'/>"/>
SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AVTs Customer Medbox, Makes Wall Street Journal MarketWatch Headlines Again
2. AVTs Customer Medbox, Inc. Featured in Bloomberg Businessweek
3. Medbox, Inc. Sees Opportunity in Several New States
4. Medbox, Inc. Comments on California Supreme Court Decision
5. Medbox, Inc. Unveils Customer Financing Program
6. Medbox, Inc. Finalizes Manufacturing Plans for 2013 Product Line
7. Medbox, Inc. Announced Increased Funding for Corporate Giving Program in 2013
8. Medbox, Inc. Commences Pursuit of Strategic Acquisitions
9. Medbox, Inc. Offers Guidance and Consultation To Washington State
10. Medbox, Inc. Protects Its Image as a Leader in Sensible Medication Dispensing
11. Medbox, Inc. at the Forefront of Providing Secure Medicine Dispensing Systems to Prisons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  A Mederi Therapeutics Inc . anunciou aprovação regulatória, pela CFDA, e ... doença do refluxo gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... Live Stretta procedure performed and broadcast during the Chinese Congress of Digestive Endoscopy, ... , , ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology:
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... , ... December 08, 2016 , ... With the increasing ... the “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the ... the dental implant and prosthetic market in the U.S. is projected to reach $6.4 ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ... been recognized for adherence to the highest standards of trauma, maternity, cancer and ... the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the ...
Breaking Medicine News(10 mins):